SCHEMBL7930049

SCHEMBL7930049

CCOC(=O)c1ccc(C=NO)nc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.59
L3MBTL1 Q9Y468 2/20 0.59
KDM4C Q9H3R0 1/20 0.51
ALOX15 P16050 4/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
APOBEC3A P31941 1/20 0.49
APOBEC3G Q9HC16 1/20 0.49
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA7 P43166 2/20 0.46
CA9 Q16790 2/20 0.46
CA14 Q9ULX7 2/20 0.46
ESR1 P03372 1/20 0.46
ESR2 Q92731 1/20 0.46
LMNA P02545 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
MAOA P21397 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29893176 1.00 KDM4E (0.59) KDM4EL3MBTL1KDM4CALOX15NPC1
SCHEMBL20419488 0.83 KDM4E (0.64) KDM4EL3MBTL1KDM4CALOX15NPC1
SCHEMBL29811161 0.83 CA12 (0.50) KDM4EL3MBTL1NPC1RAB9ACA12
SCHEMBL7926743 0.83 CA12 (0.50) KDM4EL3MBTL1NPC1RAB9ACA12
SCHEMBL31536142 0.82 CA12 (0.49) L3MBTL1NPC1RAB9ACA12CA1
SCHEMBL2622774 0.82 CA12 (0.49) L3MBTL1NPC1RAB9ACA12CA1
SCHEMBL6575685 0.77 CA12 (0.50) KDM4EL3MBTL1ALOX15NPC1RAB9A
SCHEMBL29800427 0.76 CA12 (0.56) L3MBTL1NPC1RAB9ACA12CA1
SCHEMBL659139 0.76 CA12 (0.56) KDM4EL3MBTL1NPC1RAB9ACA12
SCHEMBL27077391 0.76 KDM4E (0.72) KDM4EL3MBTL1KDM4CALOX15NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6228868-B1 ANTICARCINOGENIC AND ANTITUMOR AGENTS ABBOTT LABORATORIES 2001-05-08 US disclosed
WO-2000006556-A1 SUBSTITUTED OXAZOLINES AS ANTIPROLIFERATIVE AGENTS ABBOTT LABORATORIES (US) 2000-02-10 WO disclosed